NCT01418612已完成1 期
An Open Label, Randomised, Two Period, Two Treatment, Two Sequence, Crossover, Single-Dose Bioequivalence Study of Venlafaxine Hydrochloride Extended-Release Capsules 150mg (Test Formulation, Torrent Pharmaceutical Limited., India) Versus Effexor XR® 150mg Capsule (Reference Formulation, Wyeth Pharmaceuticals Inc., USA) in Healthy Volunteers Under Fed Conditions
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
- 主要终点
- Bioequivalence based on Composite of Pharmacokinetics
研究概览
简要总结
Objective:
The Bioequivalence studies were performed to compare the rate and extent of release of the drug substance from the two Capsule formulations containing Venlafaxine Hydrochloride Extended-Release Capsules 150mg of Torrent Pharmaceuticals Limited and the Effexor XR® (Venlafaxine Hydrochloride) Extended-Release Capsules 150mg of Wyeth Pharmaceuticals Inc., USA.
Study Design:
Open Label, Randomised, Two Period, Two Treatment, Two Sequence, Crossover, Single-Dose Bioequivalence Study of Venlafaxine Hydrochloride Extended-Release Capsules 150mg (Test formulation, Torrent Pharmaceutical Limited., India) Versus Effexor XR® 150mg capsule (Reference formulation, Wyeth Pharmaceuticals Inc., USA) in Healthy Volunteers
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •(*)The volunteers were excluded from the study based on the following criteria:
- •Sex: male.
- •Age: 18 - 45 years. .
- •Volunteer with BMI of 18-27 (inclusive both) kg/m2 with minimum of 50 kg weight.
- •Healthy and willing to participate in the study.
- •Volunteer willing to adhere to the protocol requirements and to provide written informed consent.
- •Non-smokers or smoker who smokes less than 10 cigarettes per day
排除标准
- •(*)The volunteers were excluded from the study based on the following criteria:
- •Clinically relevant abnormalities in the results of the laboratory screening evaluation.
- •Clinically significant abnormal ECG or Chest X-ray.
- •Systolic blood pressure less than 100 mm Hg or more than 140 mm Hg and diastolic blood pressure less than 60 mm Hg or more than 90 mm Hg.
- •Pulse rate less than 50/minute or more than 100/minute.
- •Oral temperature less than 95°P or more than 98.6°P.
- •Respiratory rate less than 12/minute or more than 20/minute
- •History of allergy to the test drug or any drug chemically similar to the drug under investigation.
- •History of alcohol or drug abuse
- •Positive breath alcohol test
- •Recent history of kidney or liver dysfunction.
- •History of consumption of prescribed medication since last 14 days or OTC medication since last 07 days before beginning of the study.
- •Volunteers suffering from any chronic illness such as arthritis, asthma etc.
- •History of heart failure.
- •HIV, HCV, HBsAg positive volunteers.
- •Opiate, tetra hydrocannabinol, amphetamine, barbiturates, benzodiazepines, - Cocaine positive volunteers based on urine test.
- •Volunteers suffering from any psychiatric (acute or chronic) illness requiring medications.
- •Administration of any study drug in the period 0 to 3 months before entry to the study.
- •History of significant blood loss due to any reason, including blood donation in the past 3 months.
- •History of pre-existing bleeding disorder.
- •Existence of any surgical or medical condition, which, in the judgment of the chief investigator and/or clinical investigator/physician, might interfere with the absorption, distribution, metabolism or excretion of the drug or likely to compromise the safety of volunteers.
- •Inability to communicate or co-operate due to language problem, poor mental development or impaired cerebral function.
结局指标
主要结局
Bioequivalence based on Composite of Pharmacokinetics
Bioequivalence; 90% geometric confidence interval of the ratio of least-squares means of the test to reference product should be within 80.00% - 125.00% for AUC-unf, AUCo-t and Cmax.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed ConditionsHealthyNCT01418625Torrent Pharmaceuticals Limited
已完成
1 期
Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fasting ConditionsHealthyNCT01419340Torrent Pharmaceuticals Limited
已完成
1 期
Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fed ConditionsHealthyNCT01419366Torrent Pharmaceuticals Limited
已完成
不适用
The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.To Determine Bioequivalence Under Fed ConditionsNCT05337969AET Laboratories Private Limited60
已完成
不适用
The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.To Determine Bioequivalence Under Fed ConditionsNCT05329857AET Laboratories Private Limited60